A prospective audit of the use of lamotrigine in 300 chronic pain patients

Pain Clinic

Volumn 11, Issue 2, 1998, Pages 97-102

  McCleane, G J ^a  

^a Royal Victoria Hospitals Trust   (United Kingdom)

Author keywords

Anticonvulsants; Lamotrigine; Neuropathic pain

Indexed keywords

ANTICONVULSIVE AGENT; LAMOTRIGINE;

ARTICLE; CHRONIC PAIN; CLINICAL TRIAL; DROWSINESS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL AUDIT; NAUSEA; NEUROPATHY; PROSPECTIVE STUDY; RASH; VOMITING;

EID: 0031791334     PISSN: 01691112     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Davies HT, Crombie IK, Macrae WA, Why use a pain clinic? Management of neurogenic pain before and after referral, J Royal Soc Med 87, 382-5 (1994).
2. Ollat H, Pharmacological treatment of neuropathic pain, Revue Neurologique 148, 521-31 (1992).
3. Rosner H, Rubin L, Kestenbaum A, Gabapentin adjunctive therapy in neuropathic pain states, Clin J Pain 12, 56-8 (1996).
4. Sandford PR, Lindblom LB, Haddox JD, Amitriptyline and carbamazepine in the treatment of dysesthetic pain in spinal cord injury, Arch Phys Med Rehab 73, 300-1 (1992).
5. Bartusch SL, Sanders BJ, D'Alessio JG, Jernigan JR, Clonazepam for the treatment of lancinating phantom limb pain, Clin J Pain 12, 59-62 (1996).
6. McQuay H, Carroll D, Jadad AR et al., Anticonvulsant drugs for management of pain: a systematic review, Br Med J 311, 1046-53 (1995).
7. Campbell FG, Graham JG, Zilkha KJ, Clinical trial of carbazepine (Tegretol) in trigeminal neuralgia, J Neurol Neurosurgery Psychiatry 29, 265-7 (1966).
8. Rull J, Quilbrera R, Gonzalez-Millan H et al., Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double blind crossover study, Diabetologia 5, 215-20 (1969).
9. Drewes AM, Andreasen A, Poulsen LH, Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study, Paraplegia 32, 565-9 (1994).
10. Mikati MA, Schacter SC, Schomer DL et al., Long-term tolerability, pharmacokinetic and preliminary efficacy study of lamotrigine in patients with resistant partial seizures, Clin Neuropharmacol 12, 312-21 (1989).
11. Cohen AF, Land GS, Breimer DD et al., Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans, Clin Pharmacol Therapeutics 42, 534-41 (1987).
12. Posner J, Holdich T, Crome P, Comparison of lamotrigine pharmacokinetics in young and elderly healthy volunteers, J Pharmaceutic Med 1, 121-8 (1991).
13. Posner J, Cohen AF, Land GS et al., The pharmacokinetics of lamotrigine (BW430C) in healthy subjects with unconjugated hyperbilirubinaemia (Gilbert's syndrome), Br J Pharmacol 28, 117-20 (1989).
14. Ramsay RE, Pellock JM, Garnett WR et al., Pharmacokinetics and safety of lamotrigine in patients with epilepsy, Epilepsy Res 10, 191-200 (1991).
15. Cohen AF, Ashby L, Crowley D et al., Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam, Br J Clin Pharmacol 20, 619-29 (1985).
16. Lees G, Leach MJ, Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex, Brain Res 612, 190-9 (1993).
17. Macdonald RL, Kelly KM, Antiepileptic drug mechanisms of action, Epilepsia 36, S2-S12 (1995).
18. Lang DG, Wang CM, Cooper BR, Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells, J Pharmacol Exper Therapeutics 266, 829-35 (1992).
19. Toeh H, Fowler LJ, Bowery NG, Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord, Neuropharmacology 34, 1273-8 (1995).
20. Nakamura-Craig M, Follenfant RL, Effect of lamotrigine in the acute and chronic hyperalgesia induced by PGE2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes, Pain 63, 33-7 (1995).
21. Chapman V, Wildman MA, Dickenson AH, Distinct electrophysiological effects of two spinally administered membrane stabilising drugs, bupivacaine and lamotrigine, Pain 71, 285-95 (1997).
22. Virani A, Mailis A, Shapiro LE, Shear NH, Drug interactions in human neuropathic pain pharmacotherapy, Pain 73, 3-13 (1997).
23. McQuay HJ, Tramer M, Nye BA et al., A systematic review of antidepressants in neuropathic pain, Pain 68, 217-27 (1996).
24. Sterker M, Berrouschot J, Schneider D, Fatal course of toxic epidermal necrolysis under treatment with lamotrigine, Int J Clin Pharmacol Therapeutics 33, 595-7 (1995).
25. Brodie MJ, Lamotrigine, Lancet 339, 1397-400 (1992).
26. Cohen AF, Hamilton MJ, Peck AW, Yuen WC, Lamotrigine and carbamazepine: comparison on psychomotor performance, Br J Clin Pharmacol 89, 704P (1986).
27. Umino M, Ohwatari T, Shimoyama K, Nagao M, Long-term observation of the relation between pain intensity and serum carbamazepine concentration in elderly patients with trigeminal neuralgia, J Oral Maxillofacial Surgery 51, 1338-44 (1993).
28. Schacter SC, Sauter MK, Treatment of central pain with gabapentin, J Epilepsy 9, 223-5 (1996).